Fusions were more present in GBM (90.5% of all fusion cases) than in other gliomas (9.5%; p = 0.009 F-fisher), and in particular, EGFR fusion was present in 16/17 of the patients with GBM. This evidence concerns the gene EGFR and central nervous system cancer.